rs786205570
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025074.7(FRAS1):c.8098+2T>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000000712 in 1,403,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_025074.7 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.8098+2T>A | splice_donor_variant, intron_variant | Intron 55 of 73 | 5 | NM_025074.7 | ENSP00000422834.2 | |||
FRAS1 | ENST00000682513.1 | c.8098+2T>A | splice_donor_variant, intron_variant | Intron 55 of 63 | ENSP00000508201.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.12e-7 AC: 1AN: 1403618Hom.: 0 Cov.: 31 AF XY: 0.00000144 AC XY: 1AN XY: 692404
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.8098+2T>A intronic variant results from a T to A substitution two nucleotides after coding exon 55 of the FRAS1 gene. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and will result in the creation or strengthening of a novel splice donor site. Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at